Summary
Lactoferrin (Lf) has been found in most biological fluids including amniotic fluid and cervical mucoids in pregnant women, and released from neutrophils in response to the inflammation. As Lf possesses antimicrobial properties, it is widely considered to be an important component of the host defence against microbial infections. It is known that premature labor is caused by amniotic infection with the increase of prostaglandin production. High concentration of the inflammatory cytokines: interleukin-1 β (IL-1 β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) in the amniotic fluid has been known. However, changes of Lf in amniotic fluid with infection has not been reported. In the present study, Lf concentrations in amniotic fluid were measured under the intra-uterine infections state and the biological significance of Lf was investigated. The effects of Lf on the IL-6 and IL-6mRNA production in cultured amnion cells were also investigated. The concentrations of Lf and IL-6 in amniotic fluid with CAM were 8.76±0.65 μg/ml and 6.92±4.88 ng/ml (n=28) respectively and both were significantly higher (p<0.01) than those without CAM [0.86±0.81 μg/ml and 0.34±0.25 ng/ml (n=31)]. Significant positive correlation (r=0.91, p<0.01) between Lf and IL-6 levels in amniotic fluid was found. IL-6 production induced by lipopolysaccharide (LPS) (100ng/m1) in cultured amnion cells was significantly inhibited (p<0.05) under the physiological concentration of Lf in amnion. Total RNA was extracted from the amniotic cells by guianizine solution. RT-PCR procedure and product analysis were performed from one µg aliquote of total RNA. β-actin was used as an international standard and c-DNA samples were followed by 30 cycles of PCR. RTPCR product of IL-6 mRNA was detected by Southern hybridization. Expression of IL6mRNA was inhibited by the addition of Lf. From the results, the possibility that Lf might suppress amniotic IL-6 production under the condition of amniotic infection is suggested. It is also suggested that Lf might act as self defence mechanism from intra-uterine infection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnold RR, Brewer A, Gauthier JJ. (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun, 28, 893–898
Staut J, Norell S, Harrington JP (1984) Kinetic effect of human lactoferrin on the growth of Escherichia coli 011 1. Int J Biochem, 16, 1043–1047.
Ellison RT, Giehl TJ, Laforce MF (1988) Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun, 56, 2774–278I.
Suzuki T, Yamauchi K, Kawase K, Kiyosawa I, Okonogi S. (1989) Collaborative bacteriostatic activity of bovine lactoferrin with lysozyme against Escherichia coli 0111. Agric Biol Chem, 53, 1705–1706.
Visca P, Dalmastri C, Verzili D, Antonini G, Chianocone E, Valenti P. (1990) Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med Microbiol Immunol, 179, 323–333.
Cox T, Mazurier J, Spik G, Montreuil J. Peters TJ (1979) Iron binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactoferrin receptors in the human intestine. Biochim Biophys Acta, 588, 120–128.
Lonnerdal B (1990) Iron in human milk and cow’s milk–Effects of binding ligands on bioavailability. In: Iron Metabolism in Infants, Lonnerdal B (Ed) CRC Press, Boca Rato, FL, pp 87–107.
Broxmeyer H, Gentile P, Cooper S, Lu L, Juliano L, Piacibello W, Meyers LL (1984) Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells, 10, 397–426.
Birgens HS (1991) The interaction of lactoferrin with human monocytes. Dan Med Bull, 38, 244–252.
Rudney JD (1989) Relationships between human parotid saliva lysozyme, lactoferrin, salivary peroxidase and secretory immunoglobulin A in a large sample population. Arch Oral Biol, 34, 499–506.
Cleveland MG, Bakos MA, Hilton SM, Goldblum RH (1991) Amniotic fluid: the first feeding of mucosal immune factors. Adv Exp Med Biol, 310, 41–49.
Machnicki M, Zimecki M, Zagulski T (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol, 74, 433–439.
Blanc WA (1981) Pathology of the placenta, membranes, and umbilical cord in bacterial, fungal and viral infections in man. In: Perinatal Diseases International Academy of Pathology Monograph, Vol 22, Blanc WA Ed, Williams & Wilkins, Baltimore, pp 67–132.
Dipaola C, Mandel ID (1980) Lactoferrin concentration in human parotid saliva as measured by enzyme-linked immunosorbent assay (ELISA) J Dent Res, 59, 1463–1465.
Katsufumi O, Aki Y, Kazuhiro H, Yukiko S, Hiroshi S, Takumi Y (1997) Salivary lactoferrin in neonates with chorioamnionitis. The Showa Univ J Med Sci, 9–1, unpublished
Chimura T. Hirayama T, Takase M (1993) Lactoferrin in cervical mucus of patients with chorioamnionitis. Jpn Antibiot, 46, 318–322.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Otsuki, K., Yoda, A., Toma, Y., Shimizu, Y., Saito, H., Yanaihara, T. (1998). Lactoferrin and Interleukin-6 Interaction in Amniotic Infection. In: Spik, G., Legrand, D., Mazurier, J., Pierce, A., Perraudin, JP. (eds) Advances in Lactoferrin Research. Advances in Experimental Medicine and Biology, vol 443. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9068-9_33
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9068-9_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9070-2
Online ISBN: 978-1-4757-9068-9
eBook Packages: Springer Book Archive